The effects of
benidipine hydrochloride (CAS 91559-74-5, Coniel) on autonomic nervous activity in hypertensive patients with high- and
low-salt diets were investigated. Six patients having a urinary
sodium excretion of 80 mEq/day or less (low
salt group) and 6 patients having a urinary
sodium excretion of 200 mEq/day or more (high
salt group) were orally given
benidipine hydrochloride (4 mg). Before and four weeks after the treatment with
benidipine, 24-h circadian variation in blood pressure and 24-h Holter electrocardiogram (ECG) were recorded. The low frequency power spectrum of heart rate (LF power; 0.04-0.15 Hz), high frequency power spectrum of heart rate (HF power; 0.15-0.40 Hz), and the ratio of LF to HF (LF/HF) were calculated, and these parameters were averaged every hour in every subject. HF power was significantly lower and LF/HF ratio was significantly higher in the high-
salt group than in the low-
salt group before the treatment. However, the
benidipine treatment significantly increased the HF power in both groups, particularly in the high-
salt group, and significantly decreased the LF/HF ratio in both groups. Moreover, there was no significant difference in the
antihypertensive effect of
benidipine between the high- and low-
salt intake groups. These results suggest that
benidipine favourably influences blood pressure and autonomic nervous activity in hypertensive patients with a high-
salt intake. It is concluded that
benidipine may be useful for improving the development of
salt-induced
hypertension and its accompanying haemodynamic responses.